Hunan Hansen Pharmaceutical Co.,Ltd.’s Net Profit Rose 14.9% in First Half of 2023

Hunan Hansen Pharmaceutical Co.,Ltd. (湖南汉森制药股份有限公司) (002412.SZ) reported a net profit of 90.7 million yuan in the first half of 2023, up 14.9% year-on-year.

Meanwhile, the company posted 471.7 million yuan in revenue, up 1.9% year-on-year.

At the end of the reporting period, it had 2.3 billion yuan in total assets and 433.4 million yuan in total liabilities, with a liability-to-asset ratio of 19%.